BARCELONA, Spain, July 28 (Korea Bizwire) — In 2021 the pharmaceutical company Ferrer invested 61.4% of its net profits in social and environmental causes, as part of its purpose to make a positive impact in society. As the company’s Sustainability Report states, Ferrer reinvested the major part of its profits in several projects aimed at fostering equal opportunities for [...]
BARCELONA, Spain, June 21 (Korea Bizwire) — On Global Amyotrophic Lateral Sclerosis / Motor Neuron Disease (ALS/MND) Awareness Day on June 21, the Phantasticals campaign, run by Ferrer, the pharmaceutical company, has added a new fantasy creature, with the aim of raising awareness of ALS, a rare, neurodegenerative, progressive disease that affects the motor neurons in the [...]
BARCELONA, Spain, May 5 (Korea Bizwire) — Coinciding with World Pulmonary Hypertension (PH) Day, which is celebrated every May 5, Ferrer and the European Pulmonary Hypertension Association – PHA Europe, launch the PHantasticals awareness campaign, an initiative that seeks to raise public awareness about rare and chronic pathologies in the area of pulmonary vascular and interstitial lung diseases [...]
BARCELONA, Spain, Feb. 28 (Korea Bizwire) — In the run up to Rare Disease Day, which is held on 28 February, International pharmaceutical company Ferrer has strengthened its focus on pulmonary vascular and interstitial lung diseases, as well as neurological disorders, by announcing today the signing of a distribution agreement with United Therapeutics Corporation (Nasdaq: UTHR) for Tyvaso® (treprostinil) inhalation [...]